RIZARG
DEAD

Serial Number

79189837

Owner

NOVARTIS AG

Filing Date

Jul 6, 2016

Add to watchlist:

No watchlists yet
View on USPTO

RIZARG Trademark

Serial Number: 79189837 • Registration: 5098029

RIZARG is a trademark filed by NOVARTIS AG on July 6, 2016. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

NOVARTIS AG (7,135 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

July 6, 2016

Registration Date

December 13, 2016

Published for Opposition

September 27, 2016

Cancellation Date

June 30, 2023

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; anti-fungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma

Filing History

GENERIC MADRID TRANSACTION SENT TO IB
Apr 11, 2025 XXSS
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Apr 11, 2025 INNA
GENERIC MADRID TRANSACTION CREATED
Apr 11, 2025 XXCR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Feb 29, 2024 INTR
CANCELLED SECTION 71
Jun 30, 2023 C71T
NOTIFICATION PROCESSED BY IB
Oct 27, 2017 GPNX
NOTIFICATION PROCESSED BY IB
May 12, 2017 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Feb 9, 2017 FICS
FINAL DISPOSITION PROCESSED
Feb 9, 2017 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Jan 12, 2017 GPAR
REGISTERED-PRINCIPAL REGISTER
Dec 13, 2016 R.PR
PUBLISHED FOR OPPOSITION
Sep 27, 2016 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 7, 2016 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 7, 2016 OP2R
NOTICE OF PUBLICATION
Sep 7, 2016 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 15, 2016 CNSA
APPLICATION FILING RECEIPT MAILED
Aug 12, 2016 MAFR
ASSIGNED TO EXAMINER
Aug 9, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 8, 2016 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Aug 5, 2016 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Aug 4, 2016 SDRC